1. American Journal of Kidney Diseases
K/DOQI Clinical Practice Guidelines for Cardiovascular Disease in Dialysis Patients 
American Journal of Kidney Diseases 
Volume 45, Pages (April 2005)
DOI: /j.ajkd
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

2. Fig 1
Estimated mortality of dialysis patients after acute MI. Reproduced with permission.7
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

3. Fig 2
Estimated all-cause survival of dialysis patients after CABG, PTCA, and stenting. Bars indicate SEMs. Reprinted with permission (
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

4. Fig 3
Estimated all-cause survival of dialysis patients after heart valve replacement surgery with tissue and nontissue prosthetic valves. Bars indicate standard errors. Reprinted with permission (
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

5. Fig 4 Hypertension treatment algorithm in dialysis patients.
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

6. Fig 5
Kaplan-Meier survival curves by baseline troponin levels. The number of patients at risk at baseline, 1 year, 2 years, and 2.5 years for each cutoff is shown at the bottom of the graph. The 99th percentile refers to the normal reference limit. The 10% CV refers to the lowest concentration that demonstrates a 10% total precision. The ROC cutoff refers to concentrations optimized for the sensitive and specific detection of MI. Reproduced with permission (
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

7. Fig 6
Desaturation and elongation of the major families of polyunsaturated fatty acids. Reproduced with permission.8
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions

8. Fig 7
Coronary event-free survival and apo(a) phenotypes. Adjusted results are obtained from a multiple Cox proportional hazards regression analysis. Numbers near the survival curves represent the number of patients with HMW and LMW apo(a) phenotypes at risk at the times 0, 12, 24, 36, 48 and 60 months. Reproduced with permission (
American Journal of Kidney Diseases  , DOI: ( /j.ajkd )
Copyright © 2005 National Kidney Foundation, Inc. Terms and Conditions